CLINICAL_TRIALS
trial_result
· 2012-09-13
Clinical Trial Update: Study of Sunitinib in Patients With Von Hippel-Lindau (VHL) Disease [Phase 2]
Summary
A Phase 2 trial evaluating sunitinib in patients with Von Hippel-Lindau disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | Conditions: Von Hippel-Lindau Disease | Phase 2 | Status: COMPLETED